The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: Evidence from the use of maleate

Journal of Neurosurgical Anesthesiology

Volumn 21, Issue 3, 2009, Pages 235-241

  Zlotnik, Alexander ^a   Gruenbaum, Shaun E ^a   Artru, Alan A ^c   Rozet, Irene ^c   Dubilet, Michael ^a   Tkachov, Sergey ^a   Brotfain, Evgeny ^a   Klin, Yael ^b   Shapira, Yoram ^a   Teichberg, Vivian I ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Brain injury; Glutamate; Maleate; Neurologic outcome; Oxaloacetate; Rat

Indexed keywords

ASPARTATE AMINOTRANSFERASE; GLUCOSE; GLUTAMIC ACID; MALEIC ACID; OXALOACETIC ACID; SODIUM CHLORIDE;

ADD ON THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BLOOD LEVEL; BRAIN; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFECT; DRUG INFUSION; DRUG USE; FORCE; GLUCOSE BLOOD LEVEL; HEAD INJURY; INTERSTITIAL FLUID; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; STROKE; TRAUMATIC BRAIN INJURY;

ANIMALS; ASPARTATE AMINOTRANSFERASE, CYTOPLASMIC; BEHAVIOR, ANIMAL; BLOOD GAS ANALYSIS; ENZYME INHIBITORS; GLUTAMIC ACID; HEAD INJURIES, CLOSED; MALE; MALEATES; NEUROPROTECTIVE AGENTS; OXALOACETATE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68149183176     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e3181a2bf0b     Document Type: Article

References (36)

1. Castillo J, Davalos A, Naveiro J et al. Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke. 1996;27:1060-1065. (Pubitemid 26177607)
2. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic aminoacids. Lancet. 1997;349:79-83. (Pubitemid 27023423)
3. Castillo J, Davalos A, Alvarez-Sabin J, et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 2002;58:624-629. (Pubitemid 34164947)
4. Johnston MV, Trescher WH, Ishida A, et al. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr Res. 2001;49:735-741. (Pubitemid 32522044)
5. Zauner A, Bullock R, Kuta AJ, et al. Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochir Suppl. 1996;67:40-44. (Pubitemid 126446200)
6. Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65:1-105.
7. Sattler R, Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol. 2001;24:107-129. (Pubitemid 34066681)
8. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, et al. Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience. 2009;158:301-308.
9. O'Kane RL, Martinez-Lopez I, DeJoseph MR, et al. Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem. 1999;274:31891-31895. (Pubitemid 129503776)
10. Berl S, Lajtha A, Waelsch H. Amino acid and protein metabolism of the brain. VI. Cerebral compartments of glutamic acid metabolism. J Neurochem. 1961;7:186-197.
11. Gottlieb M, Wang Y, Teichberg VI. Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem. 2003;87:119-126. (Pubitemid 37210646)
12. Palmer AM, Marion DW, Botscheller ML, et al. Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model. J Neurochem. 1993;61:2015-2024. (Pubitemid 23354056)
13. Richards DA, Tolias CM, Sgouros S, et al. Extracellular glutamine to glutamate ratio may predict outcome in the injured brain: a clinical microdialysis study in children. Pharmacol Res. 2003;48:101-109. (Pubitemid 36593365)
14. Rose ME, Huerbin MB, Melick J, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;943:15-22. (Pubitemid 34671169)
15. Baker AJ, Moulton RJ, MacMillan VH, et al. Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J Neurosurg. 1993;79:369-372.
16. Bullock R, Zauner A, Woodward JJ, et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg. 1998;89:507-518. (Pubitemid 28440917)
17. Koura SS, Doppenberg EM, Marmarou A, et al. Relationship between excitatory amino acid release and outcome after severe human head injury. Acta Neurochir Suppl. 1998;71:244-246. (Pubitemid 128444409)
18. Zhang H, Zhang X, Zhang T, et al. Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries. Clin Chem. 2001;47:1458-1462.
19. Hosoya K, Sugawara M, Asaba H, et al. Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method. J Neurochem. 1999;73:1206-1211. (Pubitemid 29395480)
20. Zlotnik A, Gurevich B, Tkachov S, et al. Brain neuroprotection by scavenging blood glutamate. Exp Neurol. 2007;203:213-220. (Pubitemid 44821179)
21. Zlotnik A, Gurevich B, Cherniavsky E, et al. The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem Res. 2008;33:1044-1050.
22. Desagher S, Glowinski J, Premont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci. 1997;17:9060-9067. (Pubitemid 27498433)
23. Crestanello JA, Lingle DM, Millili J, et al. Pyruvate improves myocardial tolerance to reperfusion injury by acting as an antioxidant: a chemiluminescence study. Surgery. 1998;124:92-99. (Pubitemid 28354691)
24. Varma SD, Devamanoharan PS, Ali AH. Prevention of intracellular oxidative stress to lens by pyruvate and its ester. Free Radic Res. 1998;28:131-135.
25. Mongan PD, Capacchione J, Fontana JL, et al. Pyruvate improves cerebral metabolism during hemorrhagic shock. Am J Physiol Heart Circ Physiol. 2001;281:H854-H864. (Pubitemid 32756112)
26. Velick SF, Vavra J. A kinetic and equilibrium analysis of the glutamic oxaloacetate transaminase mechanism. J Biol Chem. 1962;237:2109-2122.
27. Shapira Y, Shohami E, Sidi A, et al. Experimental closed head injury in rats: mechanical, pathophysiologic, and neurologic properties. Crit Care Med. 1988;16:258-265. (Pubitemid 18081907)
28. Graham LT Jr, Aprison MH. Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods. Anal Biochem. 1966;15:487-497.
29. Faden AI, Demediuk P, Panter SS, et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989;244:798-800. (Pubitemid 19163864)
30. Stoffel M, Plesnila N, Eriskat J, et al. Release of excitatory amino acids in the penumbra of a focal cortical necrosis. J Neurotrauma. 2002;19:467-477. (Pubitemid 34412054)
31. Morris GF, Juul N, Marshall SB, et al. Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial. Neurosurgery. 1998;43:1369-1372; discussion 1372-1374.
32. Muir KW. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr Opin Pharmacol. 2006;6:53-60. (Pubitemid 43103819)
33. Ikonomidou C, Turski L. Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol. 2002;1:383-386.
34. Hardingham GE, Bading H. The Yin and Yang of NMDA receptor signalling. Trends Neurosci. 2003;26:81-89. (Pubitemid 36110542)
35. Biegon A, Fry PA, Paden CM, et al. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci USA. 2004;101:5117-5122. (Pubitemid 38469212)
36. Yurkewicz L, Weaver J, Bullock MR, et al. The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J Neurotrauma. 2005;22:1428-1443. (Pubitemid 43122358)